GLUE 241220 2.50C (GLUE241220C2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

GLUE241220C2500

Watchlist

6.20
0.000.00%

15min DelayTrading Nov 1 10:44 ET

0.00High0.00Low

Intraday

5D
Daily

News

Wall Street Analysts Think Monte Rosa Therapeutics (GLUE) Could Surge 100.47%: Read This Before Placing a Bet
Zacks Nov 15 09:15 ET
Monte Rosa Therapeutics to Participate in the Jefferies London Healthcare Conference
GlobeNewswireNov 13 07:00 ET
Owning 47% Shares,institutional Owners Seem Interested in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE),
Yahoo FinanceNov 11 07:45 ET
J.P. Morgan Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Raises Target Price to $15
Moomoo NewsNov 8 22:31 ET · Ratings
Wells Fargo Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Cuts Target Price to $14
Moomoo NewsNov 8 05:31 ET · Ratings
Express News | Monte Rosa Therapeutics Inc : JP Morgan Raises Target Price to $15 From $7
ReutersNov 8 00:27 ET

Comments

MrSuperStonk

Nov 7 12:38

$Monte Rosa Therapeutics (GLUE.US)$ thats pretty good revenue. But dont buy here. wait for it to calm down.

Jaguar8

Oct 30 16:39

NEWS

$Monte Rosa Therapeutics (GLUE.US)$
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.

Jaguar8

Oct 30 15:39

NEWS

$Monte Rosa Therapeutics (GLUE.US)$
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.

Rivera

Oct 29 11:03

To 20 soon

$Monte Rosa Therapeutics (GLUE.US)$

Jaguar8

Oct 28 22:28

Watch on this. It ran today but this is a huge news- partnership with Novartis. Trade the chart

$Monte Rosa Therapeutics (GLUE.US)$